Global Continuous Glucose Monitoring Market 2021

January 2022 | 19 pages | ID: GD4534BD1C3EEN
StrategyHelix Inc

Abstracts

Diabetes is one of the top 10 causes of death globally. It causes distress, disability, and premature death. A diabetic person experiences high glucose level in their blood, either because the beta cells do not produce insulin (Type 1 diabetes) that is required for the breakdown of glucose, or because the insulin produced is not utilized properly (Type 2 diabetes). According to StrategyHelix, the global continuous glucose monitoring market is expected to increase by US$ 2,751 million during 2021-2027, expanding at a CAGR of 14.6% during the forecast period. Rise in incidence of diabetes cases, government support initiatives to constrict the spread of diabetes and increasing obesity population are expected to boost the market growth in the coming years.

The report provides up-to-date market size data for period 2017-2020 and forecast to 2027 covering key market aspects like sales value for continuous glucose monitoring. The global continuous glucose monitoring market is segmented on the basis of component, demographics, end user, and region. Based on component, the global continuous glucose monitoring market is categorized into sensors, durables (receivers and transmitter). Globally, the sensors segment made up the largest share of the continuous glucose monitoring market. On the basis of demographics, the global continuous glucose monitoring market has been segmented into child population (?14 years), adult population (>14 years). The adult population (>14 years) segment captured the largest share of the market in 2020. By end user, the global continuous glucose monitoring market has been segmented into diagnostics/clinics, ICUs, home healthcare. Geographically, the global continuous glucose monitoring market is segmented into North America, Asia Pacific, Europe, Rest of the World (ROW).

The global continuous glucose monitoring market is highly competitive. Key companies profiled in the report include A. Menarini Diagnostics S.r.l., Abbott Laboratories, Dexcom Inc., Echo Therapeutics Inc., GlySens Incorporated, Insulet Corporation, LifeScan Inc., Medtronic MiniMed Inc, Roche Diabetes Care GmbH, Senseonics Holdings Inc.

Report Scope
Component: sensors, durables (receivers and transmitter)
Demographics: child population (?14 years), adult population (>14 years)
End user: diagnostics/clinics, ICUs, home healthcare
Region: North America, Asia Pacific, Europe, Rest of the World (ROW)
Years considered: this report covers the period 2017 to 2027

Key Benefits for Stakeholders
Get a comprehensive picture of the global continuous glucose monitoring market
Pinpoint growth sectors and trends for investment

Contents

PART 1. INTRODUCTION

Scope of the study
Study period
Geographical scope
Research methodology

PART 2. CONTINUOUS GLUCOSE MONITORING MARKET OVERVIEW

PART 3. MARKET BREAKDOWN BY COMPONENT

Sensors
Durables (receivers and transmitter)

PART 4. MARKET BREAKDOWN BY DEMOGRAPHICS

Child population (?14 years)
Adult population (>14 years)

PART 5. MARKET BREAKDOWN BY END USER

Diagnostics/clinics
ICUs
Home healthcare

PART 6. MARKET BREAKDOWN BY REGION

North America
Asia Pacific
Europe
Rest of the World (ROW)

PART 7. KEY COMPANIES

A. Menarini Diagnostics S.r.l.
Abbott Laboratories
Dexcom Inc.
Echo Therapeutics, Inc.
GlySens Incorporated
Insulet Corporation
LifeScan, Inc.
Medtronic MiniMed Inc
Roche Diabetes Care GmbH
Senseonics Holdings, Inc.
About StrategyHelix
Disclaimer